Skip to main content
Fig. 4 | Lipids in Health and Disease

Fig. 4

From: Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis

Fig. 4

HDL functionality. (Panel a) Cholesterol efflux: HDL was isolated from subjects with DKD and controls and utilized as an acceptor of cellular cholesterol. Bone marrow-derived macrophages (BMDMs) overloaded with acetylated LDL and 14C-cholesterol were incubated with 50ā€‰Ī¼g of HDL/mL of medium for 6ā€‰h. Cholesterol efflux was determined after measuring the radioactivity in the culture medium and that remaining in cells, which was calculated as 14C-cholesterol in the medium/14C-cholesterol in the medium +14C-cholesterol in cells Ɨā€‰100. Control incubations were performed in the presence of DMEM/FAFA in the absence of HDL, and the results were subtracted from those obtained in the presence of HDL. (Panels b and c) Antioxidant activity: The lag time (panel b) and the maximum rate of LDL oxidation (panel c) were determined in incubations with LDL (40ā€‰Ī¼g of protein) isolated from a healthy donor with CuSO4 solution and HDL from DKD or controls (80ā€‰Ī¼g of protein). (Panels d and e) Anti-inflammatory activity: BMDMs overloaded with acetylated LDL (50ā€‰Ī¼g/mL) were treated with HDL (50ā€‰Ī¼g/mL) for 24ā€‰h. After washing, cells were treated with LPS (1ā€‰Ī¼g/mL) for 24ā€‰h, and interleukin-6 (IL-6, panel d) and TNF-alpha (panel e) levels in the medium were determined by ELISA. The results were compared by the Kruskal-Wallis test with the Holm-Sidak posttest or Studentā€™s t test

Back to article page